Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Advanced Solid Tumors × Tablets × Clear all

Sponsor

Conditions

Neoplasms 4 Leukemia, B-Cell 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Polycystic Ovary Syndrome 1 Parathyroid Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasm Metastasis 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Hairy Cell 1 Leukemia 1 Hyperparathyroidism, Primary 1 Head and Neck Neoplasms 1 Diabetes Mellitus 1 Carcinoma, Renal Cell 1 Carcinoma 1 Biliary Tract Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

tislelizumab 4 talazoparib 4 Docetaxel 4 PM 01183 2 Nivolumab 2 MLN 8237 2 Itraconazole 2 Fluorouracil 2 Cisplatin 2 Carboplatin 2 zimberelimab 1 ulixertinib 1 trifluridine tipiracil drug combination 1 sitravatinib 1 sapanisertib 1 pexidartinib 1 pevonedistat 1 peposertib 1 pembrolizumab 1 niraparib 1 mogamulizumab 1 lenvatinib 1 ixabepilone 1 eribulin 1 dalotuzumab 1 avelumab 1 ascrinvacumab 1 TLC 388 1 Rifampin 1 Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡